{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:33:52Z","timestamp":1785234832237,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00535-022-01852-0","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T17:03:13Z","timestamp":1646154193000},"page":"322-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The useful predictors of zinc deficiency for the management of chronic liver disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Soichi","family":"Iritani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-0042","authenticated-orcid":false,"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Muraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.1840080622","volume":"8","author":"JC Bode","year":"1988","unstructured":"Bode JC, Hanisch P, Henning H, et al. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology. 1988;8:1605\u20139.","journal-title":"Hepatology"},{"key":"1852_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(84)92567-4","volume":"2","author":"P Reding","year":"1984","unstructured":"Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet. 1984;2:493\u20135.","journal-title":"Lancet"},{"key":"1852_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.hepres.2004.08.013","volume":"30S","author":"K Katayama","year":"2004","unstructured":"Katayama K. Ammonia metabolism and hepatic encephalopathy. Hepatol Res. 2004;30S:73\u201380.","journal-title":"Hepatol Res"},{"key":"1852_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.1840160326","volume":"16","author":"O Riggio","year":"1992","unstructured":"Riggio O, Merli M, Capocaccia L, et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology. 1992;16:785\u20139.","journal-title":"Hepatology"},{"key":"1852_CR5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.nut.2014.04.018","volume":"30","author":"K Katayama","year":"2014","unstructured":"Katayama K, Saito M, Kawaguchi T, et al. Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial. Nutrition. 2014;30:1409\u201314.","journal-title":"Nutrition"},{"key":"1852_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/hep.510230523","volume":"23","author":"G Marchesini","year":"1996","unstructured":"Marchesini G, Fabbri A, Bianchi G, et al. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23:1084\u201392.","journal-title":"Hepatology"},{"key":"1852_CR7","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1365-2036.2010.04448.x","volume":"32","author":"Y Takuma","year":"2010","unstructured":"Takuma Y, Nouso K, Makino Y, et al. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080\u201390.","journal-title":"Aliment Pharmacol Ther"},{"key":"1852_CR8","first-page":"1968","volume":"96","author":"AT Blei","year":"2001","unstructured":"Blei AT, C\u00f3rdoba J. Practice parameters committee of the american college of gastroenterology. Hepatic Encephalopathy Am J Gastroenterol. 2001;96:1968\u201376.","journal-title":"Hepatic Encephalopathy Am J Gastroenterol"},{"key":"1852_CR9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/BF01307509","volume":"36","author":"O Riggio","year":"1991","unstructured":"Riggio O, Ariosto F, Merli M, et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991;36:1204\u20138.","journal-title":"Dig Dis Sci"},{"key":"1852_CR10","first-page":"414","volume":"2","author":"G Bresci","year":"1993","unstructured":"Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med. 1993;2:414\u20136.","journal-title":"Eur J Med"},{"key":"1852_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3164\/jcbn.jcbn08-246","volume":"45","author":"S Matsuoka","year":"2009","unstructured":"Matsuoka S, Matsumura H, Nakamura H, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr. 2009;45:292\u2013303.","journal-title":"J Clin Biochem Nutr"},{"key":"1852_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4236\/ojgas.2011.12005","volume":"1","author":"K Katayama","year":"2011","unstructured":"Katayama K, Sakakibara M, Imanaka K, et al. Effect of zinc supplementation in patients with type C liver cirrhosis. Open J Gastroenterol. 2011;1:28\u201334.","journal-title":"Open J Gastroenterol"},{"key":"1852_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3164\/jcbn.14-33","volume":"55","author":"K Iwata","year":"2014","unstructured":"Iwata K, Enomoto H, Nishiguchi S, et al. Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J Clin Biochem Nutr. 2014;55:147\u201352.","journal-title":"J Clin Biochem Nutr"},{"key":"1852_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.mam.2005.07.002","volume":"26","author":"YJ Kang","year":"2005","unstructured":"Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med. 2005;26:391\u2013404.","journal-title":"Mol Aspects Med"},{"key":"1852_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1872-034X.2012.01055.x","volume":"43","author":"E Taniguchi","year":"2013","unstructured":"Taniguchi E, Kawaguchi T, Otsuka M, et al. Nutritional assessments for ordinary medical care in patients with chronic liver disease. Hepatol Res. 2013;43:192\u20139.","journal-title":"Hepatol Res"},{"key":"1852_CR16","first-page":"38","volume":"20","author":"J Ignacio-de-Ul\u00edbarri","year":"2005","unstructured":"Ignacio-de-Ul\u00edbarri J, Gonz\u00e1lez-Madro\u00f1o A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20:38\u201345.","journal-title":"Nutr Hosp"},{"key":"1852_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","journal-title":"J Clin Oncol"},{"key":"1852_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000479984","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325\u201336.","journal-title":"Liver Cancer"},{"key":"1852_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases. Hepatology. 2020;71:306\u201333.","journal-title":"Hepatology"},{"key":"1852_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/hepr.12511","volume":"45","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatol Res. 2015;45:363\u201377.","journal-title":"Hepatol Res"},{"key":"1852_CR21","unstructured":"Russell RM, Suter PM. Vitamin and trace mineral deficiency and excess minerals, zinc. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J editors. Harrison's Principles Of Internal Medicine, 19th Ed., McGraw Hill, New York; 2015. p. 96e-9\u201396e-10."},{"key":"1852_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646\u20139.","journal-title":"Br J Surg"},{"key":"1852_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1852_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1852_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1159\/000324282","volume":"28","author":"Z Zhou","year":"2010","unstructured":"Zhou Z. Zinc and alcoholic liver disease. Dig Dis. 2010;28:745\u201350.","journal-title":"Dig Dis"},{"key":"1852_CR26","doi-asserted-by":"publisher","first-page":"G313","DOI":"10.1152\/ajpgi.00081.2014","volume":"307","author":"Q Sun","year":"2014","unstructured":"Sun Q, Li Q, Zhong W, et al. Dysregulation of hepatic zinc transporters in a mouse model of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2014;307:G313\u201322.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1852_CR27","first-page":"50","volume":"85","author":"J Wang","year":"1975","unstructured":"Wang J, Pierson RN Jr. Distribution of zinc in skeletal muscle and liver tissue in normal and dietary controlled alcoholic rats. J Lab Clin Med. 1975;85:50\u20138.","journal-title":"J Lab Clin Med"},{"key":"1852_CR28","doi-asserted-by":"publisher","first-page":"G625","DOI":"10.1152\/ajpgi.00350.2009","volume":"298","author":"W Zhong","year":"2010","unstructured":"Zhong W, McClain CJ, Cave M, et al. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2010;298:G625\u201333.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1852_CR29","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3390\/jcm8122057","volume":"8","author":"H Nishikawa","year":"2019","unstructured":"Nishikawa H, Enomoto H, Yoh K, et al. Serum zinc level classification system: usefulness in patients with liver cirrhosis. J Clin Med. 2019;8:2057.","journal-title":"J Clin Med"},{"key":"1852_CR30","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3945\/jn.115.216093","volume":"145","author":"W Zhong","year":"2015","unstructured":"Zhong W, Li Q, Sun Q, et al. Preventing gut leakiness and endotoxemia contributes to the protective effect of zinc on alcohol-induced steatohepatitis in rats. J Nutr. 2015;145:2690\u20138.","journal-title":"J Nutr"},{"key":"1852_CR31","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.3892\/mmr.2017.7262","volume":"16","author":"J Ye","year":"2017","unstructured":"Ye J, Zhang Z, Zhu L, et al. Polaprezinc inhibits liver fibrosis and proliferation in hepatocellular carcinoma. Mol Med Rep. 2017;16:5523\u20138.","journal-title":"Mol Med Rep"},{"key":"1852_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.lfs.2011.10.022","volume":"90","author":"T Kono","year":"2012","unstructured":"Kono T, Asama T, Chisato N, et al. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats. Life Sci. 2012;90:122\u201330.","journal-title":"Life Sci"},{"key":"1852_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.14740\/jocmr3374w","volume":"10","author":"K Katayama","year":"2018","unstructured":"Katayama K, Kawaguchi T, Shiraishi K, et al. The prevalence and implication of zinc deficiency in patients with chronic liver disease. J Clin Med Res. 2018;10:437\u201344.","journal-title":"J Clin Med Res"},{"key":"1852_CR34","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/nu9121286","volume":"9","author":"I Wessels","year":"2017","unstructured":"Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients. 2017;9:1286.","journal-title":"Nutrients"},{"key":"1852_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12986-015-0023-4","volume":"12","author":"P Ranasinghe","year":"2015","unstructured":"Ranasinghe P, Wathurapatha WS, Ishara MH, et al. Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond). 2015;12:26.","journal-title":"Nutr Metab (Lond)"},{"key":"1852_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10620-006-9462-0","volume":"52","author":"I Stamoulis","year":"2007","unstructured":"Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci. 2007;52:1595\u2013612.","journal-title":"Dig Dis Sci"},{"key":"1852_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.2503871","volume":"245","author":"MS Lee","year":"1989","unstructured":"Lee MS, Gippert GP, Soman KV, et al. Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science. 1989;245:635\u20137.","journal-title":"Science"},{"key":"1852_CR38","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1038\/sj.emboj.7600248","volume":"23","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Tashiro S, Hira S, et al. Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J. 2004;23:2544\u201353.","journal-title":"EMBO J"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-022-01852-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T15:13:56Z","timestamp":1647875636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-022-01852-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s00535-022-01852-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"19 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(1) Yusuke Kawamura has received honoraria from Eisai Co., Ltd, and TERUMO CORPORATION, Chugai Pharmaceutical Co., Ltd. (2) Masahiro Kobayashi has received honoraria from Eisai Co., Ltd. (3) Norio Akuta has received honoraria from AbbVie GK and Gilead Sciences Inc. (4) Hiromitsu Kumada has received honoraria from AbbVie GK, Gilead Sciences Inc., Eisai Co., Ltd, and MSD. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}